Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low exhaled nitric oxide as a predictor of response to inhaled corticosteroids in suspected asthma
2016-000338-23Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Budesonide with Placebo (2 arms). Primary endpoint: Asthma Control Questionnaire (ACQ-7) change. Started Feb 2016; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2016-000338-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000338-23.